The U.S. Centers for Medicare & Medicaid Services (CMS) has released a preliminary list of 101 generic drugs that would be ...
Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.
Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...
The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...
Cobenfy's journey from the lab through regulatory approval is a case study in how America's world-class scientists work to ...
Bad actors are using online ads, social media and bootleg ingredients to sell fake, inaccurate and harmful versions of these ...
Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...
America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...
You will be able to provide input into which medications are covered under Medicaid Monday during a virtual meeting hosted by ...
Steep costs have driven some Aussies to switch from brand-name medicine to its generic counterpart. Here's the price ...
In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...